Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-15

Clinical Trial Update: Caffeine Versus Placebo for Spinal Headaches [NA]

View source ↗

Summary

A clinical trial comparing caffeine to placebo for post-dural puncture headache has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)

Snippet

Sponsor: United States Naval Medical Center, Portsmouth | Conditions: Post Dural Puncture Headache | NA | Status: WITHDRAWN